Free Trial

Synaptogenix (SNPX) Insider Trading & Ownership

Synaptogenix logo
$2.96
-0.02 (-0.67%)
(As of 11/1/2024 ET)

Synaptogenix (NASDAQ:SNPX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.33%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$54,609.75
Get SNPX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Synaptogenix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SNPX Insider Buying and Selling by Quarter

Synaptogenix Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/16/2022Daniel L AlkonInsiderSell787$29.25$23,019.75  
12/16/2022William S SingerDirectorSell1,080$29.25$31,590.00  
(Data available from 1/1/2013 forward)

SNPX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Synaptogenix includes Daniel L Alkon, and William S Singer. Learn more on insiders at SNPX.

4.33% of Synaptogenix stock is owned by insiders. Learn more on SNPX's insider holdings.

The following insiders have sold SNPX shares in the last 24 months: Daniel L Alkon ($23,019.75), and William S Singer ($31,590.00).

Insiders have sold a total of 1,867 Synaptogenix shares in the last 24 months for a total of $54,609.75 sold.

Synaptogenix Key Executives

  • Dr. Alan J. Tuchman M.D. (Age 77)
    MBA(FAAN), CEO & Director
    Compensation: $303.35k
  • Dr. Daniel L. Alkon M.D. (Age 82)
    President, Chief Scientific Officer & Director
    Compensation: $375k
  • Mr. Robert Weinstein (Age 64)
    CFO, Executive VP, Treasurer & Secretary
    Compensation: $568.92k


This page (NASDAQ:SNPX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners